| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |